Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - FATE THERAPEUTICS INC | Financial_Report.xls |
10-K - 10-K - FATE THERAPEUTICS INC | a2223519z10-k.htm |
EX-31.1 - EX-31.1 - FATE THERAPEUTICS INC | a2223519zex-31_1.htm |
EX-32.1 - EX-32.1 - FATE THERAPEUTICS INC | a2223519zex-32_1.htm |
EX-32.2 - EX-32.2 - FATE THERAPEUTICS INC | a2223519zex-32_2.htm |
EX-31.2 - EX-31.2 - FATE THERAPEUTICS INC | a2223519zex-31_2.htm |
EX-10.25 - EX-10.25 - FATE THERAPEUTICS INC | a2223519zex-10_25.htm |
EX-10.24 - EX-10.24 - FATE THERAPEUTICS INC | a2223519zex-10_24.htm |
EX-10.26 - EX-10.26 - FATE THERAPEUTICS INC | a2223519zex-10_26.htm |
EX-10.23 - EX-10.23 - FATE THERAPEUTICS INC | a2223519zex-10_23.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements
- 1.
- Registration
Statement (Form S-3 No. 333-199107) of Fate Therapeutics, Inc., and
- 2.
- Registration Statements (Form S-8 Nos. 333-191576 and 333-194625) pertaining to the 2007 Equity Incentive Plan, the 2013 Stock Option and Incentive Plan, and 2013 Employee Stock Purchase Plan of Fate Therapeutics, Inc.;
of our report dated March 12, 2015, with respect to the consolidated financial statements of Fate Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young
San
Diego, CA
March 12, 2015
Consent of Independent Registered Public Accounting Firm